The DCI supports training across the continuum by sponsoring a monthly seminar series, retreats for all the individual disease programs, and the annual off-site DCI Scientific Retreat with trainee talks, a robust poster session and an invited external speaker. Recent speakers have included Douglas R. Lowy, MD (NCI), Matt Meyerson, MD, PhD (Dana-Farber Cancer InstituteI), Sean Morrison, PhD (UT Southwestern), Levi Garraway, MD, PhD (Dana-Farber Cancer Institute) and John Mendelsohn, MD (MD Anderson). The annual retreat provides an outstanding opportunity for the entire Duke cancer research community to meet and network, including basic, clinical, translation and population scientists, and provides an opportunity for both PhD and MD trainees across the continuum to present their work.
The DCI also supports training across the continuum through Shared Resources and Developing Shared Resources. Most of these Shared Resources provide expertise and training to DCI members and trainees, including assistance with preparation of grants using their services and individual training. The DCI Shared Resources present its work annually to the DCI Executive Committee and present posters at the DCI Annual retreat.
In addition, each DCI Research Program helps the DCI execute its education and training mission across the training continuum. In each program DCI members teach high school students, undergraduates, medical students, graduate students, post-doctoral fellows, residents and fellows including through lectures, disease based research meetings, seminars, work in progress meetings, tumor boards and program retreats.
In addition, in each program, DCI members provide shadowing experiences, serve as teaching faculty on the wards, serve as mentors on clinical, translational and basic research projects, participate in career development events including lectures and mock study sections.
The DCI has partnered with the Duke Global Health Institute to form the Duke Global Cancer Initiative (DGCI), directed by DCI member, Nelson Chao, MD, MBA. The DGCI is charged with expanding cancer research, education and clinical care in poor countries (not sure poor countries is the way to phrase this). With efforts in Tanzania, Brazil, India and China, the DCGI promotes global cancer research education by sponsoring physician-scientist cancer researchers, medical students and medical residents and fellows to spend time in our partner countries, and get research projects going.
The DGCI is currently supporting pediatric oncologist, Kristin Schroeder, MD, to spend 50 percent of her effort in Mwanza, Tanzania, where she is investigating how to improve access to cancer care. In addition, Laura Musselwhite, MD, MPH, a current medical oncology fellow and NIH Fogarty Global Health Fellow has been sponsored to travel to Brazil, where she has begun cervical cancer screening projects that are now being supported by the Bill & Melinda Gates Foundation.The DGCI also promotes global cancer research education by sponsoring seminars on global cancer and an annual Global Cancer Symposium, with speakers from our partner countries.
The National Cancer Institute funded North Carolina Central University (NCCU) – DUKE Cancer Disparities Translational Research Partnership (NCCU-DCI-CDTRP), directed by Kevin Williams, PhD (NCCU) and deputy director of DCI Steven Patierno, PhD, is developing the infrastructure for translational cancer health disparities research, education and training for graduate students and postdoctoral fellows, with pilot research projects focusing on the molecular aspects underlying the increased lethality of prostate and inflammatory breast cancer in African Americans. This has direct application to prevention, detection and treatment. The program provides laboratory training, and a robust Translational Immersion Experience (TIE) program that spans the translation spectrum for underrepresented minority trainees including in depth, hands-on exposure in clinical trial operations, clinical care, and community and patient engagement.
The DCI Office of Health Equity, together with it’s partners in the Duke Health Disparities Consortium — which includes the Center For Bio-Behavioral Health Disparities Research, the Duke Consortium on Social Equity, the Duke Office of Diversity & Inclusion and the Duke Office for Institutional Equity — has instituted a patient navigator system, with one of the goals being to educate healthcare system personnel on structural, cultural, and healthcare system barriers that impact access to and utilization of cancer screening services and resources.
Duke Cancer Institute constellates the world-class resources of Duke University, Duke Health and the Duke Comprehensive Cancer Center into a collaborative powerhouse. We are poised to drive a paradigm shift in the way long-established cancer centers and institutes have been waging this war.Learn More